As of 2025-06-24, the EV/EBITDA ratio of Cytosorbents Corp (CTSO) is -5.94. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CTSO's latest enterprise value is 81.49 mil USD. CTSO's TTM EBITDA according to its financial statements is -13.73 mil USD. Dividing these 2 quantities gives us the above CTSO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 19.6x - 23.1x | 21.5x |
| Forward P/E multiples | 22.6x - 23.4x | 23.0x |
| Fair Price | (5.00) - (5.10) | (4.91) |
| Upside | -496.9% - -504.9% | -490.0% |
| Date | EV/EBITDA |
| 2025-06-11 | -5.16 |
| 2025-06-10 | -5.02 |
| 2025-06-09 | -5.12 |
| 2025-06-06 | -5.02 |
| 2025-06-05 | -4.98 |
| 2025-06-04 | -4.75 |
| 2025-06-03 | -4.75 |
| 2025-06-02 | -4.10 |
| 2025-05-30 | -4.02 |
| 2025-05-29 | -3.93 |
| 2025-05-28 | -4.02 |
| 2025-05-27 | -3.93 |
| 2025-05-23 | -4.04 |
| 2025-05-22 | -4.06 |
| 2025-05-21 | -4.16 |
| 2025-05-20 | -4.02 |
| 2025-05-19 | -4.07 |
| 2025-05-16 | -4.29 |
| 2025-05-15 | -4.00 |
| 2025-05-14 | -3.88 |
| 2025-05-13 | -4.16 |
| 2025-05-12 | -4.16 |
| 2025-05-09 | -4.16 |
| 2025-05-08 | -4.16 |
| 2025-05-07 | -4.22 |
| 2025-05-06 | -4.25 |
| 2025-05-05 | -4.33 |
| 2025-05-02 | -4.48 |
| 2025-05-01 | -4.80 |
| 2025-04-30 | -4.80 |
| 2025-04-29 | -5.30 |
| 2025-04-28 | -5.16 |
| 2025-04-25 | -5.21 |
| 2025-04-24 | -5.48 |
| 2025-04-23 | -5.07 |
| 2025-04-22 | -5.21 |
| 2025-04-21 | -5.16 |
| 2025-04-17 | -4.89 |
| 2025-04-16 | -4.84 |
| 2025-04-15 | -4.80 |
| 2025-04-14 | -4.71 |
| 2025-04-11 | -4.62 |
| 2025-04-10 | -4.48 |
| 2025-04-09 | -4.48 |
| 2025-04-08 | -4.57 |
| 2025-04-07 | -4.71 |
| 2025-04-04 | -4.61 |
| 2025-04-03 | -4.71 |
| 2025-04-02 | -4.75 |
| 2025-04-01 | -4.75 |